[Reevaluation of equivocal HER2 status detected by immunohistochemistry according to the 2019 guidelines for HER2 detection]

Authors :: W M, Xu
L N, Zhang
H L, Jin
J J, Zhou
Z Y, Wang
S X, Weng
Y J, Li
P, Zhou
M F, Gan
Source :: Zhonghua bing li xue za zhi = Chinese journal of pathology. 49(11)
Publication Year :: 2020
Abstract: O

Subjects :: China
Receptor, ErbB-2
Biomarkers, Tumor
Humans
Breast Neoplasms
Immunohistochemistry
In Situ Hybridization, Fluorescence

Tools